247 related articles for article (PubMed ID: 28053071)
1. Mouse Models for Drug Discovery. Can New Tools and Technology Improve Translational Power?
Zuberi A; Lutz C
ILAR J; 2016 Dec; 57(2):178-185. PubMed ID: 28053071
[TBL] [Abstract][Full Text] [Related]
2. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
3. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.
Wang HX; Li M; Lee CM; Chakraborty S; Kim HW; Bao G; Leong KW
Chem Rev; 2017 Aug; 117(15):9874-9906. PubMed ID: 28640612
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Genome Editing and In Vivo Delivery.
Ramirez-Phillips AC; Liu D
AAPS J; 2021 Jun; 23(4):80. PubMed ID: 34080099
[TBL] [Abstract][Full Text] [Related]
5. Use of CRISPR/Cas9 gene-editing tools for developing models in drug discovery.
Ahmad G; Amiji M
Drug Discov Today; 2018 Mar; 23(3):519-533. PubMed ID: 29326075
[TBL] [Abstract][Full Text] [Related]
6. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
[TBL] [Abstract][Full Text] [Related]
7. Gene editing and its applications in biomedicine.
Li G; Li X; Zhuang S; Wang L; Zhu Y; Chen Y; Sun W; Wu Z; Zhou Z; Chen J; Huang X; Wang J; Li D; Li W; Wang H; Wei W
Sci China Life Sci; 2022 Apr; 65(4):660-700. PubMed ID: 35235150
[TBL] [Abstract][Full Text] [Related]
8. Development and application of CRISPR/Cas9 technologies in genomic editing.
Zhang C; Quan R; Wang J
Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
[TBL] [Abstract][Full Text] [Related]
9. CRISPR-Cas9: A revolution in genome editing in rheumatic diseases.
Duroux-Richard I; Giovannangeli C; Apparailly F
Joint Bone Spine; 2017 Jan; 84(1):1-4. PubMed ID: 27825565
[No Abstract] [Full Text] [Related]
10. Enabling Precision Medicine with CRISPR-Cas Genome Editing Technology: A Translational Perspective.
Ilahibaks NF; Hulsbos MJ; Lei Z; Vader P; Sluijter JPG
Adv Exp Med Biol; 2023; 1396():315-339. PubMed ID: 36454475
[TBL] [Abstract][Full Text] [Related]
11. Translating genomic insights into cardiovascular medicine: Opportunities and challenges of CRISPR-Cas9.
Zhang Y; Karakikes I
Trends Cardiovasc Med; 2021 Aug; 31(6):341-348. PubMed ID: 32603681
[TBL] [Abstract][Full Text] [Related]
12. CRISPR/Cas9: at the cutting edge of hepatology.
Pankowicz FP; Jarrett KE; Lagor WR; Bissig KD
Gut; 2017 Jul; 66(7):1329-1340. PubMed ID: 28487442
[TBL] [Abstract][Full Text] [Related]
13. Redefining mouse transgenesis with CRISPR/Cas9 genome editing technology.
Burgio G
Genome Biol; 2018 Feb; 19(1):27. PubMed ID: 29490686
[TBL] [Abstract][Full Text] [Related]
14. Delivery approaches for CRISPR/Cas9 therapeutics in vivo: advances and challenges.
Luther DC; Lee YW; Nagaraj H; Scaletti F; Rotello VM
Expert Opin Drug Deliv; 2018 Sep; 15(9):905-913. PubMed ID: 30169977
[TBL] [Abstract][Full Text] [Related]
15. CRISPR/Cas9-based genome engineering of zebrafish using a seamless integration strategy.
Luo JJ; Bian WP; Liu Y; Huang HY; Yin Q; Yang XJ; Pei DS
FASEB J; 2018 Sep; 32(9):5132-5142. PubMed ID: 29812974
[TBL] [Abstract][Full Text] [Related]
16. Progress and Perspective of CRISPR-Cas9 Technology in Translational Medicine.
Zheng R; Zhang L; Parvin R; Su L; Chi J; Shi K; Ye F; Huang X
Adv Sci (Weinh); 2023 Sep; 10(25):e2300195. PubMed ID: 37356052
[TBL] [Abstract][Full Text] [Related]
17. Advances in therapeutic CRISPR/Cas9 genome editing.
Savić N; Schwank G
Transl Res; 2016 Feb; 168():15-21. PubMed ID: 26470680
[TBL] [Abstract][Full Text] [Related]
18. Advances in therapeutic application of CRISPR-Cas9.
Sun J; Wang J; Zheng D; Hu X
Brief Funct Genomics; 2020 May; 19(3):164-174. PubMed ID: 31769791
[TBL] [Abstract][Full Text] [Related]
19. Analysis of microsatellite instability in CRISPR/Cas9 editing mice.
Huo X; Du Y; Lu J; Guo M; Li Z; Zhang S; Li X; Chen Z; Du X
Mutat Res; 2017 Mar; 797-799():1-6. PubMed ID: 28284774
[TBL] [Abstract][Full Text] [Related]
20. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
Doetschman T; Georgieva T
Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]